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Abstract 
 
This paper aims to relate the principles of Ronald Coase Theorem with negative 
impacts of biotechnology, taking cases of specific research groups and 
medium-sized companies in biotechnology. We consider an application of 
economic theory on transaction costs (TEC) provides a good foundation for 
understanding the underlying problems of this sector, even more, when 
analyzing the political economy of biotechnology since the transaction costs can 
best viewed their limitations and the limited scope of government policy. In 
biotechnology it is possible to get a policy that combines both equity and 
efficiency, that is, a wider range of policy applications to improve the living 
standards of people in Colombia. 
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1 - Overview and Hypothesis 
 
 
 
1.1 Impact of Biotechnology 
 
Biotechnology has made a profound impact on agriculture and food industry the 
world over the past 15 years (Phillips, 2002; Herdt, 2006:; Dahlandera and 
Gannb, 2010; biotecVisions 2011)1. Companies in developed and emerging 
countries have broadly adopted innovations in genetically modified (GM) with 
their relative advantages (Lusk, Jamal, Kurland, Rouco, Taulman, 2005, Qaim 
and Zilberman, 2003). What has led to efficiency gains ranging from higher 
yields, lower costs to control weeds and pests and diseases of depressed 
populations, the same way there have been significant environmental benefits 
(Pray, Paarlberg and Unnevehr, 2007). The evolution of the expectations and 
forecasts on crops with improved agronomic characteristics, and new 
ingredients in the food production potential of an extraordinary nature are, 
according to some researchers (Gaskell, 2006). Who observe these 
advantages, consider the fulfillment of the promises implicit in biotechnology 
requires overcoming barriers of restrictive regulations on genetically modified 
(Zilberman, 2006)2. However, there are problems that go beyond the legislative 
framework (McHugh, 2007). Mainly in countries with institutional imbalances, 
economic imbalances and limited investment in the development of scientific 
knowledge. 
 
The concept of biotechnology as a key technology for emerging agricultural 
applications overflows obtained after multiple applications made basic 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The advent of biotechnology has presented major challenges for the food industry worldwide. However, 
while the scientific basis for food production are part of a revolution, it is unclear how to implement 
technologies for biotechnology advocates and much of agrifood policy makers around the world project a 
positive future technology overcomes the food shortages, improving the environment, eliminates disease 
and leads to healthy and prosperous societies. However, a reverse reaction expressed by consumers and 
environmental advocates have founded arguments for considering that biotechnology represents, in 
contrast, exacerbation of food insecurity, environmental threats and hazards to human security, 
ultimately, worsening global society. This thesis does not take a stand against these dilemmas, but rather 
we are interested in seeing how responsive government institutions and the implementation of 
biotechnology, in particular, if public policy in Colombia provide the conditions to adapt or innovate 
biotechnology so that it can improve the quality of life and welfare of a majority of its population. 
2 For an extensive argument on the subject of regulations, see: Ian M. Sheldon (2002), although the author 
responds to an excessive reliance on the rules of the World Trade Organization, which is observed in the 
policies of emerging technology, are relatively complex problems between collective action and 
institutions, as justifies the present investigation.	  
procedures for millennia by breeding and application of microorganisms in the 
food chain production3. The DNA rediscovery and new knowledge for handling, 
constitute a tipping point that opens many new opportunities for use and 
application of biological resources. From this perspective, the potential impact 
of biotechnology on society with new products and processes, and initiation of 
new technologies are an important source of added value to the innovation 
capacity of companies in different industrial sectors (Raney, 2006). 
Biotechnology and genetic processes have advanced a reality with new 
challenges (Colciencias, 2008). According to this understanding of the potential 
of these technologies to improve productivity and articulated in different lines of 
business, also support to biotechnology as a strategic sector of the economy in 
many countries as Colombia, in general, biotechnology is a special field public 
policy requirements imposed by an economic geography of international 
(Colciencias, 2008; McCann, 2011). 
 
For countries like Colombia, the importance of developing the biotechnology 
sector within its borders, is also based on contemporary economic vision for the 
generation of competitive advantages as an engine of growth and development 
for the country. Biotechnology creates opportunities to promote the entry into 
new markets and create jobs in high level international qualification. Additional 
jump from one of peasant agricultural economy towards high value added 
sectors of biotechnological base is a challenge of considerable scope. What 
major changes can also predict the development of Colombian society in many 
areas4. 
 
On the other hand, are considerable opportunities provided by biotechnology to 
reduce problems related to hunger and malnutrition phenomena in many 
nations (Prakash, 2010)5. The techniques used could enhance global food 
production by more than 25% (Prakash, 2010.). An improvement in the capacity 
of the land to absorb minerals, have a greater level of productivity, allowing 
continuous planting, obtain resistant crops harsh weather, pests and diseases, 
foods with higher nutrient levels and counteract the deficiency of vitamin A , 
'cause of blindness in these nations, and iron, which affects physical and mental 
delays and is causing major nutritional disorder worldwide killing half a million 
newborns per year (Lisinge, 2000, p.113) - are some of the direct benefits 
generated by this technology. The importance of such biotechnology 
applications is necessary not only for the current humanitarian crisis figures, but 
from the effects of climate change (Prakash, 2010)6. The conditions are still 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 View and Santa Ana Andre Valle. Silvio (1995), "Public perception of biotechnology: problems in the 
Third World", Tibtech, Vol XIII. The thesis of the authors discovered that there are many prejudices in 
public policy related to a poor and widespread misinformation. 
4 Indeed, Colombia is considered one of the most attractive countries in the field of biotechnology 
applications from international markets in new technologies, see: (Myers, Sexton and Tomek, 2010). 
5 The conditions of the famine in Somalia is a sign that the economies of developed countries have not yet 
managed to create conditions to make way for public policies in the poorest countries. The case of 
Somalia is a typical case of imbalances in the global economy and severe disturbances of the local 
economy policies.	  
6 The planet's climate change by the process gases caused by human activity, generate multi-million 
dollar losses to the agricultural sector. The increase in temperature and changing rainfall patterns will 
affect crops of rice, cotton, coffee, sugar, rice, cassava, corn and soybeans, among others. In general, 
several countries are expected to decrease areas suitable for agricultural crops. The set of alternatives to 
critical gaps in policy load with global reach, as shown in the table below 
schematic: 
 
 
 
* Information from FAO, 2006. 
 
 
However, while global investment in agricultural research by the private sector 
continues to grow thanks to the growth of markets and the emergence of new 
technologies in developed countries (Alfranca and Huffman, 2001), the 
additional investment by the public sector and Governments in many poor 
countries has stagnated or declined (Byerlee and Echeverria, 2002). This 
research explores how the evolutionary dynamics between the public and 
private, with respect to the generation of new knowledge, adversely affects the 
diffusion of public policies on technological innovation, while offering 
advantages to the private sector on external support. Paradoxically, the best 
applications of those technologies that contribute to poverty reduction (Byerlee 
and Fischer, 2002). Comparing the recent historical evidence on private sector 
investment in agricultural biotechnology data, the findings indicate that a more 
open and international, with further expansion into agricultural research can be 
sensitive to addressing poverty (CGIAR, 2005a, 2005b; Dorward, Kydd, 
Morrison, Urey, 2004), only to the extent that the public sector leadership is 
reinforced by governments can change those conditions. The design of public 
policy-oriented research in biotechnology (Hall, 2005) should reassign the 
functions of private sector research (Kherallah and Kirsten, 2001). A public 
policy on biotechnology with an organizational system that is used in agriculture 
for the benefit of emerging countries, as in the case of Colombia7. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
address the problem posed by the movement of crops to new regions with better climatic conditions, 
generating millions in losses for the countries, or breeding to withstand climate change. 
7 This argument ignores the affirmative character who has had private initiative in biotechnology, but this 
makes collective coordination failures and public policy in countries with basic food needs. It is precisely 
such imbalances important premises of this research. Not many private investors willing to put their 
capital at the service of public causes. This phenomenon is not confined to emerging countries, but also 
the design of public policies in Europe and the United States, see: Nature biotechnology, "Firms seek new 
models to access public equity", volume 27 number 10 october 2009. 
 
 
 
Concern about the concentration of power in the new bioeconomics8, especially 
in the private sector in developed countries, from the use of patents, is valid 
justifications (Calestous.2002, Lesing, 2004). The trend towards the 
privatization of knowledge resulting from the research priorities determined by 
the financial return on investment, raises the possibility that the benefits of 
these favors only those with the necessary purchasing power (Leisinger, 2004. 
this sense, it poses important limitations to be imposed to the potential of 
biotechnology to improve farm productivity in developing countries and poor 
regions inhabited mostly by poor social class and low income. The problem is 
how to mitigate the effects poverty, hunger and malnutrition. In general the 
situation previously described, raises the urgent need to strengthen investment 
in research by the public sector, which for 2000 was only 20% of total 
investments at international similarly, the establishment of more partnerships 
between the public and private sectors. A public policy on biotechnology in 
Colombia should promote a correction to the income imbalance between private 
and public, as well as encourage people with children Social opportunities 
(Amartya Sen, 1997)9. 
 
On the other hand, the strategic importance of biotechnology has forced us to 
rethink mechanisms for their promotion in many developed nations and 
emerging countries in recent decades 10 . The complexity of biotechnology 
expertise derived from the multiplicity of agencies involved, and the resources 
required, further suggests the desirability of an environment that allows 
coordination to provide the necessary incentives to eliminate or reduce potential 
obstacles to development. In connection with this, the role played by 
governments is essential. In Colombia, many applications of scientific 
developments in biotechnology and the country's potential in this field, related to 
comparative advantages in terms of biodiversity, have prompted government 
agencies to make changes in order to coordinate the efforts made in isolation 
during the last decade in order to institutionalize their development. 
 
 
1.3 Formulation of government 
 
 
In this sense, in Colombia since the early nineties made the first steps to 
institutionalize the biotechnology program through the Department of 
Administrative Science, Technology and Innovation Colciencias. In 1991 under 
Agreement No. 1 of the National Council of Science and Technology, created 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8 The term does not define exactly a business school or mainstream markets in biotechnology, but 
includes a growing tendency to operate with capital in countries with important biodiversity reserves as 
Colombia. 
9 They are still outstanding contributions of Amartya Sen to reflect that originally raised an objection to 
the principles analytical expression of utilitarianism Pareto, as well as the criticism required by the first 
version of distributive justice of John Rawls. 
10 Again, André Sant'Ana and Silvio Street, "Public perception of biotechnology: problems in the Third 
World", Journal BTech, April 1995 (Vol. 13). The authors emphasized the mid 90's the strategic nature of 
biotechnology and the need to increase public awareness of it.	  
the National Biotechnology Program (GNP) as a component of the National 
Science and Technology, whose technical secretariat would be responsible for 
Colciencias, and whose creation was understood as a recognition of the 
strategic importance for the country (Castellanos, 2006.2). Later, in 1997, 
determine the lines of action and activities of GNP in 1998 would result in the 
formulation of the Strategic Plan 1999-2004 National Biotechnology Program, 
as a means of planning and prioritization of areas of research (p. 2.). 
 
 
 
According to this line of action the Ministry of Foreign Trade, decided in 2000 to 
include biotechnology as one of the key areas in the National Exporter of New 
Technologies, the National Planning Department (DNP) defines biotechnology 
as an area In conducting an exercise on its focus, likewise, the group of 
Biogestión National University jointly with the Ministry of Commerce, Industry 
and Tourism Colciencias, made the proposal for an Industrial Policy in 
Biotechnology, The Institute Alexander von Humboldt published a key 
document in 2000 BioTrade in reference to the close relationship between 
international markets for biotechnology and bio-demand and considers this 
technology as a key factor to improve the benefits provided by natural 
resources has Colombia. Similarly, the national government through the 
Ministry of Agriculture said biotechnology as an instrument to support 
technological upgrading of agriculture to the North American Free Trade 
Agreement with the United States (Cano, 2003). 
 
 
The relevance of public policy on biotechnology has also been highlighted in the 
documents Conpes 3527 of "National Policy on Competitiveness and 
Productivity", Conpes 3582 National Policy on Science, Technology and 
Innovation, Conpes 3080 of "National Policy on Science and Technology 2000 -
2002 ". And in the 2002-2006 National Development Plan "Towards a 
Communitarian State" refers to biotechnology as a "strategic area for 
development and competitiveness of the country" (Colciencias, 2008, p.31.) 
 
 
In June 2011 under the government of President Juan Manuel Santos Conpes 
approving the 3697 Policy for Business Development in Biotechnology from the 
Sustainable Use of Biodiversity, to which public policy is formalized in 
biotechnology in Colombia. Among the policy objectives are: 1 - Create the 
economic, technical, institutional and legal resources for attracting public and 
private development companies and products based on the country's 
biodiversity; 2 - Improving the institutional capacity to commercial development 
of biotechnology, 3 - Develop a set of economic instruments to attract public 
investment in business development and biotechnology products, 4 - Adapt and 
revise the regulatory framework related to access to genetic resources, 
production and marketing of biotech medicines and herbal products, 5-Evaluate 
the creation of the national bioprospecting. 
 
 
Finally, in the "Basis of National Development Plan: Towards Democratic 
Prosperity: Vision 2010 -2014," within the locomotives for growth and 
generating new agricultural products and innovation-based sectors recognize 
the importance of sustainable biodiversity and the development of 
biotechnology as key elements in improving growth and competitiveness 
(Conpes, 3697). Today, interest in developing the potential of biotechnology to 
produce knowledge Colombia is consistent with the tendency to regard science 
and technology as key issues that urgently need to be incorporated into the 
public agenda. Not in vain with the enactment in 2009 of the Law on Science 
and Technology, aims to identify strategic sectors for improving the 
competitiveness of the country from the comparative advantages, such as 
biotechnology11. 
 
Notwithstanding the foregoing, it is necessary to state that any development of 
the biotechnology sector requires additional factors to the creation of public 
documents. Need to build an adequate institutional framework and perform a 
successful intervention by the government "environment interaction between 
academia, the private and public, and eventually lead to what is the rationale for 
biotechnology: the generation of new biotechnology-based companies 
"(Colciencias, 2008). In turn, the latter two requirements need to be based on a 
correct diagnosis of the state of the art development of biotechnology in 
Colombia. That is: 
 
 
It requires knowledge of the potential, the progress and status of 
biotechnology in the country, to generate public policies that enable the 
development of this line of knowledge for the benefit of the Colombian 
business sector and citizens12. 
 
The public sector plays a key role during the development of science and 
technology. The cases of countries that have made significant progress in these 
fields corroborate this claim. Reason is that "biotechnology has become the 
workhorse of policy makers" (Pinilla, 2004, p.2). On the other complementary to 
the above has commented that: 
 
 
 
The implementation of biotechnology requires public policy decisions 
and investment. However, such decisions are as long as there is public 
will built from knowledge of what happens in different social fields in the 
scientific, economic and cultural. From this desire, and based on 
exercises of decision making are proposed and investment policy 
instruments (Pinilla, 2004, p.3). 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11  "Biotechnology: Colombia strategic sector for 2015," Colciencias, Ministry of Education, 
http://www.mineducacion.gov.co/cvn/1665/article-161751.html). 
12 Ibid  
In turn, the strategic importance of biotechnology should be incorporated into 
the agenda of different public policies. One of the main reasons for this idea is 
supported by studies showing that: 
 
 
 
Developing countries increasingly dependent on knowledge and 
innovation capacity. (Perez) stated that biotechnology is a technological 
paradigm, and as such, affects the entire structure of production from 
the production of agricultural inputs and outputs, to the food industry, the 
mining and processing of minerals to human health and animal . If steel 
has been referred to as a key factor to achieve the industrial revolution, 
or the chip in the computer age, this new revolution is key genetic 
resources. Biotechnology has been used as one of their key arguments 
ability to meet the nutritional challenges of the third world (Pinilla, 
2004.p.2). 
 
 
 
 
Regarding public policy, they should aim at reducing obstacles facing the 
development of biotechnology in Colombia. Indeed, the biotechnology 
production occurs in an environment characterized by the existence of 
imperfect competition in the presence of monopolies as well as problems of 
coórdination, market risk, uncertainty, opportunism and inefficiencies arising 
from existing institutions, among others. Terms theoretical problems reminiscent 
of neoclassical thinking in relation to the characteristics of markets, and prove 
the existence of transaction costs. 
 
 
 
 
1.4 Failure of government and market failures 
 
The technological development in Colombia has two serious limitations. The 
first relates to the characteristics of the markets that have specific benefits for 
foreign-invested sector, namely companies with economies of scale projections 
and potential for exploitation of natural resources. The second is the shape 
government policy, with obvious mismatches also associated with an 
investment in key sectors such data were limited to the development of 
populations. In short, the policy has introduced technology-related governance 
failures and lack of resources imbalances, if you compare it with the initiatives 
that have accompanied the private sector13. 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 Concern about government failures and market failures does not correspond only to emerging 
countries, the presidential message of 2010 targeted at farmers' society in the United States, contains a 
vehement demand for collective action and public policy. View David Blandford, "Presidential Address: 
The Visible or Invisible Hand? The Balance Between Markets and Regulation in Agricultural Policy 
"(2010). 
In these cases, government failures and market failures correspond to 
inefficiencies associated with the structure and design policies improved 
technology. Many biotechnology-based companies have operated on conditions 
beyond ex post policy decisions of government and governments in Colombia 
itself offered no technology-based policies with additional incentives for the 
private sector. One of the gaps in technology-based policy has been to consider 
biotechnology as a subsidiary of other sectors of the national production, which 
limits their relevance research leading to inefficient results. By failing to provide 
equilibrium conditions in the markets, the various governments away the 
possibility of opening benefits a key sector for growth and development. If 
public policy is limited in dictating restrictive rules, employers are losing 
incentives to help with investments in areas that benefit the population. 
 
 
 
The biotechnology market in Colombia also presents information gaps. Policy 
documents containing obvious gaps on the conditions of the firms that invest in 
the sector. As data gaps are, individually, investors can not solve. In summary, 
these mismatches disorient both the government and the private sector. There 
is confusion about copyrights, patents and recognition of capital flowing into 
these markets. The consequences of this situation play an inefficient use of 
natural resources are there in much of the country's geography. Subsequently 
extended these considerations. 
 
This research aims to link these negative impacts of technology policy 
improvisation, taking cases of specific research groups and medium-sized 
companies in biotechnology. We consider an application of economic theory on 
transaction costs (TEC) provides a good foundation for understanding the 
underlying problems of this sector, even more, when analyzing the political 
economy of biotechnology since the transaction costs can best viewed their 
limitations and the limited scope of government policy. In biotechnology it is 
possible to get a policy that combines both equity and efficiency, that is, a wider 
range of policy applications to improve the standard of living of the population in 
Colombia. 
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